Product Information

JOURNAVX 50 MG TABLET is a brand product labeled by Vertex Pharmaceuticals Incorporated, priced at $15.4130 per EA under NDC 51167054834. Its NADAC has been published 62 times since Jun 18, 2025.

FDA first approved this application on Jan 30, 2025.

JOURNAVX 50 MG TABLET

Suzetrigine
$15.4130per EA

Strength

50 mg/1

NDC

51167054834

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

7/1/2026

Active Ingredients

SUZETRIGINE

Approval Type

New Drug (NDA)

FDA Application

NDA219209

FDA Approved

1/30/2025

On Market Since

1/30/2025

Pharmacological Classes

Cytochrome P450 3A Inducers
Sodium Channel Antagonists
Sodium Channel Blocker

Price Statistics

The NADAC for JOURNAVX 50 MG TABLET has been published 62 times since Jun 18, 2025, and over the history we have for it it has risen 3.8%. The table below summarizes its recorded NADAC range and movement.

Current price$15.4130 per EA
All-time high$15.4130 (Aug 19, 2026)
All-time low$14.8386 (Jun 17, 2026)
52-week high$15.4130
52-week low$14.8386
Median price$14.8514
Average price$14.9117
Largest weekly change+3.9% (Jul 8, 2026)
Weeks tracked62
Tracking sinceJun 18, 2025

Price History

1W

0.0%

1M

0.0%

3M

+3.8%

6M

+3.8%

1Y

+3.8%

3Y

N/A

5Y

N/A

All

+3.8%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of JOURNAVX 50 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for JOURNAVX 50 MG TABLET, manufactured by Vertex Pharmaceuticals Incorporated, is $15.4130 per EA (NDC 51167054834), effective Aug 19, 2026.

How has the price of JOURNAVX 50 MG TABLET changed over time?

Over the history we have for it, the NADAC for JOURNAVX 50 MG TABLET has risen 3.8%. It has been tracked across 62 weekly CMS publications since Jun 18, 2025.

What are the highest and lowest recorded NADAC prices for JOURNAVX 50 MG TABLET?

Since Jun 18, 2025, the NADAC for JOURNAVX 50 MG TABLET has ranged from a low of $14.8386 (Jun 17, 2026) to a high of $15.4130 (Aug 19, 2026), with a median of $14.8514 per EA.

Are there cheaper alternatives to JOURNAVX 50 MG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as JOURNAVX 50 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures JOURNAVX 50 MG TABLET?

JOURNAVX 50 MG TABLET (NDC 51167054834) is labeled by Vertex Pharmaceuticals Incorporated, and CMS classifies it as a brand product.